Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence

Leistungen

Ensuring that Valitacell product and associated has the required CE registration

Submission of results and outline of applicability and benefits of technology in a report to be published in a peer reviewed journal or online publication

Results exchanged

Review of the results from the four sites and analysis of same in order to determine the final model to be adopted in the product

Veröffentlichungen

High-throughput quantitation of Fc-containing recombinant proteins in cell culture supernatant by fluorescence polarization spectroscopy

Autoren: Ben Thompson, Jerry Clifford, Mike Jenns, Andrew Smith, Ray Field, Kalpana Nayyar, David C. James
Veröffentlicht in: Analytical Biochemistry, Ausgabe 534, 2017, Seite(n) 49-55, ISSN 0003-2697
Herausgeber: Academic Press
DOI: 10.1016/j.ab.2017.07.013

Rechte des geistigen Eigentums

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Antrags-/Publikationsnummer: EP 15736411
Datum: 2015-06-18
Antragsteller: VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Antrags-/Publikationsnummer: EP 15718799
Datum: 2015-04-02
Antragsteller: VALITACELL LTD

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Antrags-/Publikationsnummer: EP 15736411
Datum: 2015-06-18
Antragsteller: VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Antrags-/Publikationsnummer: EP 15718799
Datum: 2015-04-02
Antragsteller: VALITACELL LTD

chemstress

Antrags-/Publikationsnummer: TM 017262511
Datum: 2018-02-12
Antragsteller: VALITACELL LTD

chemstress

Antrags-/Publikationsnummer: TM 017262511
Datum: 2018-02-12
Antragsteller: VALITACELL LTD

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Antrags-/Publikationsnummer: EP 14830805
Datum: 2014-12-17
Antragsteller: VALITACELL LTD